ORIC Pharmaceuticals Inc. 68622P109 06/18/2026 To approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3540777 0 FOR 3540777 FOR ORIC Pharmaceuticals Inc. 68622P109 06/18/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 3540777 0 FOR 3540777 FOR Revolution Medicines Inc 76155X100 06/18/2026 To approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (“Say-on-Pay”) SECTION 14A SAY-ON-PAY VOTES ISSUER 46 0 FOR 46 FOR Surrozen, Inc. 86889P208 05/13/2026 Approval, on an advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1916950 0 FOR 1916950 FOR Surrozen, Inc. 86889P208 05/13/2026 Advisory vote on the preferred frequency of the advisory vote on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1916950 0 FOR 1916950 FOR